
What This Longevity Investor Knows That You Don't | Karl Pfleger, Founder of AgingBiotech.info, Co-Hosted with Dr. Greg Bailey, Chairman of Juvenescence
Longevity for Investors with Dr. Greg Bailey and Jess Larsen
00:00
How geroscience multiplies commercial value
Karl explains that targeting fundamental ageing could enable label expansion and multiple indications, multiplying a drug’s commercial impact.
Transcript
Play full episode